Ion-selective interface engineering for durable electrolysis of impure water.

Fei-Yue Gao, Jun Xu, Haifeng Shen, Jing-Wen DuanMu, Mietek Jaroniec, Yao Zheng, Shi-Zhang Qiao

Abstract read

In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Effect of SiOChemSusChem · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fei-Yue GaoSchool of Chemical Engineering, The University of Adelaide, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0002-3811-7509

Jun XuSchool of Chemical Engineering, The University of Adelaide, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0001-6917-0751

Haifeng ShenSchool of Chemical Engineering, The University of Adelaide, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0002-0744-5518

Jing-Wen DuanMuFuture Industries Institute, UniSA STEM, University of South Australia, Mawson Lakes Campus, Adelaide, SA, Australia.

Mietek JaroniecDepartment of Chemistry and Biochemistry & Advanced Materials and Liquid Crystal Institute, Kent State University, Kent, OH, USA.ORCID http://orcid.org/0000-0002-1178-5611

Yao ZhengSchool of Chemical Engineering, The University of Adelaide, Adelaide, SA, Australia. yao.zheng01@adelaide.edu.au.ORCID http://orcid.org/0000-0002-2411-8041

Shi-Zhang QiaoSchool of Chemical Engineering, The University of Adelaide, Adelaide, SA, Australia. s.qiao@adelaide.edu.au.

Funding

Department of Education and Training | Australian Research Council (ARC) DP240102575Department of Education and Training | Australian Research Council (ARC) FT200100062

6 · The paper itself

Abstract

Electrolysis of low-grade impure water offers a sustainable approach to hydrogen production. However, unstable interfacial pH caused by electrochemical reactions accelerates ion-induced electrode degradation. Here, we show an ion-selective gate strategy, in which ion-conducting polymer coatings are applied onto commercial platinum carbon and iridium oxide catalysts to enable selective ion transport and to stabilize the interfacial pH. Compared with conventional aqueous electrolytes, this solid-state configuration effectively suppresses local pH fluctuations and blocks the migration of detrimental impurity ions. The ion-selective gate achieves nearly complete rejection of common ions found in seawater, river and lake water, and industrial wastewater, demonstrating broad adaptability to impurity-rich environments. In untreated seawater, the ion-selective gate engineered electrode operates stably for 1500 h at 200 mA cm

Identifiers

PMID41290677

DOI10.1038/s41467-025-66711-x

PMCPMC12749462

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.